449
Views
25
CrossRef citations to date
0
Altmetric
Articles

Do You Get What You Paid For? An Examination of Products Advertised as Kratom

, Ph.D., J.D., , M.S. & , Ph.D.
Pages 330-335 | Received 13 May 2016, Accepted 08 Aug 2016, Published online: 26 Sep 2016

References

  • Ahmad, K., and Z. Aziz. 2012. Mitragyna speciosa use in the northern states of Malaysia: A cross-sectional study. Journal of Ethnopharmacology 141 (1):446–50. doi:10.1016/j.jep.2012.03.009.
  • Anwar, M., and J. Schier. 2016. Notes from the field: Kratom (Mitragyna speciosa) exposures reported to poison centers: United States, 2010–2015. Morbidity and Mortality Weekly Report 65:748–49. doi:10.15585/mmwr.mm6529a4.
  • Avula, B., S. Sagi, Y.-H. Wang, M. Wang, Z. Ali, T. J. Smillie, I. A. Khan. 2015. Identification and characterization of indole and oxindole alkaloids from leaves of mitragyna speciosa korth using liquid chromatography–accurate QToF mass spectrometry. Journal of AOAC International 98 (1):13–21. doi:10.5740/jaoacint.14-110.
  • Babu, K. M., C. R. McCurdy, and E. W. Boyer. 2008. Opioid receptors and legal highs: Salvia divinorum and kratom. Clinical Toxicology 46 (2):146–52. doi:10.1080/15563650701241795.
  • Baron, M., M. Elie, and L. Elie. 2011. An analysis of legal highs—Do they contain what it says on the tin? Drug Testing and Analysis 3 (9):576–81. doi:10.1002/dta.274.
  • Boyer, E. W., K. M. Babu, J. E. Adkins, C. R. McCurdy, and J. H. Halpern. 2008. Self‐treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction 103 (6):1048–50. doi:10.1111/add.2008.103.issue-6.
  • Chittrakarn, S., P. Penjamras, and N. Keawpradub. 2012. Quantitative analysis of mitragynine, codeine, caffeine, chlorpheniramine and phenylephrine in a kratom (Mitragyna speciosa Korth.) cocktail using high-performance liquid chromatography. Forensic Science International 217 (1):81–86. doi:10.1016/j.forsciint.2011.10.027.
  • Cinosi, E., G. Martinotti, P. Simonato, D. Singh, Z. Demetrovics, A. Roman-Urrestarazu, J.-H. Li. 2015. Following “the roots” of kratom (Mitragyna speciosa): The evolution of an enhancer from a traditional use to increase work and productivity in Southeast Asia to a recreational psychoactive drug in Western countries. Biomed Research International 2015:1–11. doi:10.1155/2015/968786.
  • Desmond, D. P., J. F. Maddux, and A. Trevino. 1978. Street heroin potency and deaths from overdose in San Antonio. The American Journal of Drug and Alcohol Abuse 5 (1):39–49. doi:10.3109/00952997809029259.
  • Eisenman, S. W. 2014. The botany of Mitragyna speciosa (Korth.) Havil. and related species. Kratom and Other Mitragynines: The Chemistry and Pharmacology of Opioids from a Non-Opium Source 57:57–76.
  • Hassan, Z., M. Muzaimi, V. Navaratnam, N. H. Yusoff, F. W. Suhaimi, R. Vadivelu, C. P. Muller. 2013. From kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction. Neuroscience & Biobehavioral Reviews 37 (2):138–51. doi:10.1016/j.neubiorev.2012.11.012.
  • Jansen, K. L., and C. J. Prast. 1988. Psychoactive properties of mitragynine (kratom). Journal of Psychoactive Drugs 20 (4):455–57. doi:10.1080/02791072.1988.10472519.
  • Kamei, J., and M. Ohsawa. 1997. Role of noradrenergic functions in the modification of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes. Life Sciences 60 (15):PL223–PL228. doi:10.1016/S0024-3205(97)00074-X.
  • Karinen, R., J. T. Fosen, S. Rogde, and V. Vindenes. 2014. An accidental poisoning with mitragynine. Forensic Science International 245:e29–e32. doi:10.1016/j.forsciint.2014.10.025.
  • Kikura-Hanajiri, R., M. Kawamura, T. Maruyama, M. Kitajima, H. Takayama, and Y. Goda. 2009. Simultaneous analysis of mitragynine, 7-hydroxymitragynine, and other alkaloids in the psychotropic plant “kratom” (Mitragyna speciosa) by LC-ESI-MS. Forensic Toxicology 27 (2):67–74. doi:10.1007/s11419-009-0070-5.
  • Kitajima, M., K. Misawa, N. Kogure, I. M. Said, S. Horie, Y. Hatori, H. Takayama. 2006. A new indole alkaloid, 7-hydroxyspeciociliatine, from the fruits of Malaysian Mitragyna speciosa and its opioid agonistic activity. Journal of Natural Medicines 60 (1):28–35. doi:10.1007/s11418-005-0001-7.
  • Kowalczuk, A. P., A. Łozak, and J. K. Zjawiony. 2013. Comprehensive methodology for identification of kratom in police laboratories. Forensic Science International 233 (1):238–43. doi:10.1016/j.forsciint.2013.09.016.
  • Kronstrand, R., M. Roman, G. Thelander, and A. Eriksson. 2011. Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton. Journal of Analytical Toxicology 35 (4):242–47. doi:10.1093/anatox/35.4.242.
  • Lesiak, A. D., R. B. Cody, A. J. Dane, and R. A. Musah. 2014. Rapid detection by direct analysis in real time-mass spectrometry (DART-MS) of psychoactive plant drugs of abuse: The case of Mitragyna speciosa aka “kratom.” Forensic Science International 242:210–18. doi:10.1016/j.forsciint.2014.07.005.
  • Limsuwanchote, S., J. Wungsintaweekul, N. Keawpradub, W. Putalun, S. Morimoto, and H. Tanaka. 2014. Development of indirect competitive ELISA for quantification of mitragynine in Kratom (Mitragyna speciosa (Roxb.) Korth.). Forensic Science International 244:70–77. doi:10.1016/j.forsciint.2014.08.011.
  • Nelsen, J. L., J. Lapoint, M. J. Hodgman, and K. M. Aldous. 2010. Seizure and coma following kratom (Mitragynina speciosa Korth) exposure. Journal of Medical Toxicology 6 (4):424–26. doi:10.1007/s13181-010-0079-5.
  • Oder, M. 2015, June 8. Addiction in a bottle: Liquid kratom available at gas stations in Birmingham. http://wiat.com/2015/06/08/addiction-in-a-bottle-liquid-kratom-available-in-at-gas-stations-in-birmingham/.
  • Oliveira, A. S., S. Fraga, F. Carvalho, A. M. Araújo, C. C. Pereira, J. P. Teixeira, P. G. De Pinho. 2016. Chemical characterization and in vitro cyto-and genotoxicity of “legal high” products containing kratom (Mitragyna speciosa). Forensic Toxicology 34:213–226.
  • Parrott, A. 2004. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology 173 (3–4):234–41. doi:10.1007/s00213-003-1712-7.
  • Philipp, A. A., D. K. Wissenbach, S. W. Zoerntlein, O. N. Klein, J. Kanogsunthornrat, and H. H. Maurer. 2009. Studies on the metabolism of mitragynine, the main alkaloid of the herbal drug kratom, in rat and human urine using liquid chromatography–linear ion trap mass spectrometry. Journal of Mass Spectrometry 44 (8):1249–61. doi:10.1002/jms.1607.
  • Posch, T. N., N. Martin, M. Pütz, and C. Huhn. 2012. Nonaqueous capillary electrophoresis–mass spectrometry: A versatile, straightforward tool for the analysis of alkaloids from psychoactive plant extracts. Electrophoresis 33 (11):1557–66. doi:10.1002/elps.201100682.
  • Rosenbaum, C. D., S. P. Carreiro, and K. M. Babu. 2012. Here today, gone tomorrow… and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. Journal of Medical Toxicology 8 (1):15–32. doi:10.1007/s13181-011-0202-2.
  • Saingam, D., S. Assanangkornchai, A. F. Geater, and Q. Balthip. 2013. Pattern and consequences of krathom (Mitragyna speciosa Korth.) use among male villagers in southern Thailand: A qualitative study. International Journal of Drug Policy 24 (4):351–58. doi:10.1016/j.drugpo.2012.09.004.
  • Schmidt, M. M., A. Sharma, F. Schifano, and C. Feinmann. 2011. “Legal highs” on the net—Evaluation of UK-based websites, products and product information. Forensic Science International 206 (1):92–97. doi:10.1016/j.forsciint.2010.06.030.
  • Schwarz, A. 2016, January 2. Kratom, an addict’s alternative, is found to be addictive itself. The New York Times A12.
  • Scott, T. M., J. K. Yeakel, and B. K. Logan. 2014. Identification of mitragynine and O‐desmethyltramadol in kratom and legal high products sold online. Drug Testing and Analysis 6 (9):959–63. doi:10.1002/dta.1673.
  • Singh, D., C. P. Müller, and B. K. Vicknasingam. 2014. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug and Alcohol Dependence 139:132–37. doi:10.1016/j.drugalcdep.2014.03.017.
  • Sukrong, S., S. Zhu, N. Ruangrungsi, T. Phadungcharoen, C. Palanuvej, and K. Komatsu. 2007. Molecular analysis of the genus Mitragyna existing in Thailand based on rDNA ITS sequences and its application to identify a narcotic species: Mitragyna speciosa. Biological & Pharmaceutical Bulletin 30 (7):1284–88. doi:10.1248/bpb.30.1284.
  • Suwanlert, S. 1975. A study of kratom eaters in Thailand. Bulletin on Narcotics 27 (3):21–27.
  • Swogger, M. T., E. Hart, F. Erowid, E. Erowid, N. Trabold, K. Yee, … Z. Walsh. 2015. Experiences of kratom users: A qualitative analysis. Journal of Psychoactive Drugs 47 (5):360–67. doi:10.1080/02791072.2015.1096434.
  • Thornton, M. 1998. The potency of illegal drugs. Journal of Drug Issues 28 (3):725. doi:10.1177/002204269802800309.
  • Vicknasingam, B., S. Narayanan, G. T. Beng, and S. M. Mansor. 2010. The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. International Journal of Drug Policy 21 (4):283–88. doi:10.1016/j.drugpo.2009.12.003.
  • Wang, M., E. J. Carrell, Z. Ali, B. Avula, C. Avonto, J. F. Parcher, and I. A. Khan. 2014. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants. Journal of Separation Science 37 (12):1411–18. doi:10.1002/jssc.v37.12.
  • Winstock, A. R., and J. D. Ramsey. 2010. Legal highs and the challenges for policy makers. Addiction 105 (10):1685–87. doi:10.1111/j.1360-0443.2010.02934.x.
  • Yusoff, N. H., F. W. Suhaimi, R. K. Vadivelu, Z. Hassan, A. Rümler, A. Rotter, V. Navaratnam. 2016. Abuse potential and adverse cognitive effects of mitragynine (kratom). Addiction Biology 21 (1):98–110. doi:10.1111/adb.12185.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.